Histone H3K27 acetylation mediated by KAT8 maintains antiviral trained immunity in shrimp induced by inactivated white spot syndrome virus.

Commun Biol

Shandong Provincial Key Laboratory of Animal Cells and Developmental Biology, School of Life Sciences, Shandong University, Qingdao, Shandong, China.

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Shrimp aquaculture is critically important for global food security, but viral diseases like white spot syndrome virus (WSSV) cause devastating economic losses, highlighting the urgent need for effective disease control strategies. While trained immunity has been observed in invertebrates like shrimp after exposure to pathogens, the underlying molecular mechanisms remain elusive. Here we reveal that lysine acetyltransferase KAT8-mediated histone H3K27ac is critical for antiviral defense in shrimp Marsupenaeus japonicus. We demonstrate that ultraviolet-inactivated WSSV (UV-WSSV) induces antiviral trained immunity in the shrimp via KAT8-dependent H3K27ac. UV-WSSV training enhances glycolysis and the tricarboxylic acid (TCA) cycle, increasing acetyl-CoA production. This acetyl-CoA fuels KAT8 activity, depositing H3K27ac marks at the promoter of the NF-κB-like transcription factor Dorsal. This epigenetic modification upregulates Dorsal expression, leading to the enhanced production of the antiviral cytokine Vago5 and antimicrobial peptides (AMPs) upon subsequent WSSV challenge. Furthermore, H3K27ac directly activates key glycolytic genes (Hk2, Pk, Ldh), creating a feedforward loop that sustains metabolic reprogramming. Our work reveals a conserved KAT8-H3K27ac axis driving trained immunity in invertebrates through integrated metabolic-epigenetic crosstalk, analogous to mammalian systems. These findings provide a crucial theoretical foundation for developing antiviral vaccines and sustainable immunostimulants to control disease in shrimp aquaculture.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12398525PMC
http://dx.doi.org/10.1038/s42003-025-08767-5DOI Listing

Publication Analysis

Top Keywords

trained immunity
16
antiviral trained
8
immunity shrimp
8
white spot
8
spot syndrome
8
syndrome virus
8
shrimp aquaculture
8
shrimp
6
antiviral
5
histone h3k27
4

Similar Publications

Hematopoietic stem and progenitor cells as a reservoir for trained immunity.

Elife

September 2025

Department of Pediatrics, Division of Infectious Diseases, and Stem Cells and Regenerative Medicine Center, Baylor College of Medicine and Texas Children's Hospital, Houston, United States.

Human and murine studies reveal that innate immune cells are able to mount enhanced responses to pathogens after primary inflammatory exposure. Innate immune memory has been shown to last for months to years, longer than the lifespan of most innate immune cells. Indeed, long-lived hematopoietic stem and progenitor cells (HSPCs) serve as a cellular reservoir for innate immune memory.

View Article and Find Full Text PDF

Kidney transplant recipients face a high risk of acute rejection (AR), where the immune system attacks the transplanted organ. Current diagnostics rely on invasive biopsies with procedural risks, costs, and limited temporal resolution. While urinary chemokines CXCL9 and CXCL10 are promising non-invasive AR biomarkers, clinical adoption is limited by labor-intensive detection and lack of point-of-care (POC) solutions.

View Article and Find Full Text PDF

Microneedle-Delivered Multivalent MPXV DNA Vaccines Induce Promising Immunity Profiles and Cross-Protection in Mice.

Immunology

September 2025

National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Key Laboratory of Biosafety, National Health Commissions, National Institute for Viral Disease Control and Prevention, China CDC, Beijing, China.

Traditional DNA vaccines, typically administered via intramuscular injection with electroporation (IM-E), often cause discomfort and require trained personnel. Addressing these challenges, we developed multivalent DNA vaccines targeting both intracellular mature virion (IMV) and extracellular enveloped virion (EEV) proteins of the monkeypox virus (MPXV), designated as M2 (A29L, B6R), M3 (A29L, B6R, M1R) and M4 (A29L, B6R, M1R, A35R). These vaccine constructs were formulated into dissolvable microneedle array patches (D-MAPs) for intradermal delivery.

View Article and Find Full Text PDF